A study was carried out in Gweru urban district (population-158233) in Zimbabwe to determine the impact of measles vaccine applied at 9 months of age on measles transmission patterns. A retrospective observational study that used data from measles vaccination records and measles disease surveillance was conducted. Linear regression analysis and the chi-squared test for linear trend (χ2) were used to investigate linear relationships at a 5% significance level. Vaccine coverage rates were 0% in pre-vaccination era in 1960-70 and 2-92% in 1971-89 (median=65, Q1=34, Q3=88) when they significantly linearly increased (p<0.001). In 1960-85 measles incidence rates significantly linearly increased (p<0.001) while in 1986-89 at vaccine coverage rates of >90% incidence rates significantly linearly declined (p<0.001). Proportion of vaccinated cases among measles notifications significantly linearly increased as vaccine coverage rates increased (Slope: +1.19, 95% CI [0.52, 1.86]). At vaccine coverage rates of >80% (1984-89), proportion of vaccine failures among cases aged 60-119 months was significantly higher than at vaccine coverage rates of <80% (1971-83) (p=0.011) while in age group 10-59 months proportions of vaccine failures were not different at vaccine coverage rates of <80% and >80%. In age group 60-119 months incidence rates significantly linearly increased as vaccine coverage rates increased (Slope: +29.88, 95 CI [13.95, 45.82]). In pre-vaccination era, and at vaccine coverage rates of <80% and >80% some 75% of all reported measles cases occurred by age 36-47 months, 48-59 months and 72-83 months respectively. In conclusion, measles incidence rates declined at vaccine coverage rates of >90%, while measles vaccine failures significantly increased as vaccine coverage rates increased. Increasing measles vaccination coverage led to shift of age at infection from age group <59 months to age group 60-119 months and decline in rates of measles transmission.
Published in | European Journal of Preventive Medicine (Volume 4, Issue 3) |
DOI | 10.11648/j.ejpm.20160403.13 |
Page(s) | 65-72 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2016. Published by Science Publishing Group |
Measles Vaccination, Impact, Transmission Patterns
[1] | Goodson JL, Masresha BG, Wannemuehler K, Uzicanin A, Cochi S. Changing epidemiology of measles in Africa. J Infect Dis 2011; 204 Suppl 1: S205-14. |
[2] | Moss WJ. Measles still has a devastating impact in unvaccinated populations. PLoS Med 2007; 4(1): e24. |
[3] | Marufu T, Siziya S, Tshimanga M, Murugasampillay S, Mason E, Manyame B. Factors associated with measles complications in Gweru, Zimbabwe. East Afr Med J 2001; 78(3): 135-8. |
[4] | ZimStat. Census 2012. Preliminary report. Zimbabwe National Statistics Agency, Harare, Zimbabwe, 2010. http://unstats.un.org/unsd/demographic/sources/census/2010_phc/Zimbabwe/ZWE_CensusPreliminary2012.pdf. Accessed 23 March 2016. |
[5] | Conlan AJ, Grenfell BT. Seasonality and the persistence and invasion of measles. Proc Biol Sci 2007; 274(1614): 1133-41. |
[6] | Ferrari MJ, Grenfell BT, Strebel PM. Think globally, act locally: the role of local demographics and vaccination coverage in the dynamic response of measles infection to control. Philos Trans R Soc Lond B Biol Sci 2013; 368(1623): 20120141. |
[7] | Earn DJ, Rohani P, Bolker BM, Grenfell BT. A simple model for complex dynamical transitions in epidemics. Science 2000; 287(5453): 667-70. |
[8] | May RM, Anderson RM. Spatial heterogeneity and the design of immunization programs. Mathematical Biosciences 1984; 72(1): 83-111. |
[9] | Anderson RM, May RM. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. J Hyg (Lond) 1985; 94(3): 365-436. |
[10] | Foster SO. Measles, the ultimate challenge in urban immunization In: Universal child immunization-Reaching the urban poor, Urban Examples. New York, UNICEF, 1990. |
[11] | Global Program for Vaccines of World Health Organization. Global measles strategy picks up pace. In: Summary of consultation on strategies to accelerate global measles control held on 27-28 April 1994; PAHO headquarters, Washington DC. |
[12] | Center for Disease Control and Prevention. Global measles mortality, 2000-2008 MMWR Morb Mortal Wkly Rep 2009; 58(47): 1321-6. |
[13] | Keeling MJ, Rhani P. Modelling infectious diseases in humans and animals. Princeton: Princeton University Press 2008. |
[14] | Goldhaber-Fiebert JD, Lipsitch M, Mahal A, Zaslavsky AM, Salomon JA. Quantifying child mortality reductions related to measles vaccination. PLoS One; 2010; 5(11): e13842. |
[15] | Rosenthal SR, Clements CJ. Two-dose measles vaccination schedules. Bull World Health Organ 1993; 71(3-4): 421-8. |
[16] | Marufu T, Siziya S, Tshimanga M, Xaba E, Ruwodo C, Silape Z, et al. Challenges posed by changes in measles transmission patterns. Cent Afr J Med 1998; 44(1): 5-8. |
[17] | Marufu T, Siziya S, Manyame B, Xaba E, Silape-Marufu Z, Zimbizi P, et al. Questioning the level of efficacy of the measles vaccine in use in Zimbabwe. Cent Afr J Med 1995; 41(8): 241-5. |
[18] | Global Programme for Vaccines and Immunization. Immunization Policy. Expanded Programme on Immunization, WHO/EPI/GEN/92.3. WHO. Geneva: WHO; 1995. |
[19] | Coetzee N, Hussey GD, Visser G, Barron P, Keen A. The 1992 measles epidemic in Cape Town- a changing epidemiological pattern S Afr Med J 1994; 84(3): 145-9. |
[20] | De Quadros CA, Olive JM, Hersh BS, Strassburg MA, Henderson DA, Brandling-Bennett D, et al. Measles elimination in the Americas- Evolving strategies. JAMA 1996; 275 (3): 224-9. |
[21] | Cutts FT, Lessler J, Metcalf CJ. Measles elimination: progress, challenges and implications for rubella control. Expert Rev Vaccines 2013; 12(8): 917-32. |
[22] | World Health Organization. Meeting of the Strategic Advisory Group of Experts on Immunization, November 2012 - conclusions and recommendations. Wkly Epidemiol Rec; 88(1): 1-16. |
[23] | Moss WJ, Strebel P. Biological feasibility of measles eradication. J Infect Dis 2011; 204 Suppl 1: S47-53. |
[24] | De Quadros CA, Andrus JK, Danovaro-Holliday MC, Castillo-Solorzano C. Feasibility of global measles eradication after interruption of transmission in the Americas. Expert Rev Vaccines 2008; 7(3): 355-62. |
[25] | Andrus JK, de Quadros CA, Solorzano CC, Periago MR, Henderson DA. Measles and rubella eradication in the Americas Vaccine 2011; 29 Suppl 4: D91-6. |
[26] | Expanded Programme on Immunization. Measles control in the 1990s: Plan of action for global measles control 1992; WHO/EPI/GEN/92.3. |
[27] | Cutts F. Expanded Programme on Immunization-Measles control in the 1990s: Principles for the next decade, 1990; WHO/EPI/GEN/90.2. |
[28] | Marufu T, Siziya S. Impact of multiple dose measles vaccination on measles transmission patterns in Gweru, Zimbabwe. J Trop Pediatr 2001; 47(6): 335-8. |
[29] | Marufu T, Siziya S, Tinago W. Comparison of single dose and multiple dose measles vaccination strategies on measles transmission patterns. European Journal of Preventive Medicine 2015; 3(3): 80-84. Doi: 10.116488/j.ejpm.20150303.18. |
[30] | Khuri-Bulos NA. Measles in Jordan: a prototype of the problems with measles in developing countries. Pediatr Infect Dis J 1995; 14(1): 22-6. |
[31] | Kambarami RA, Nathoo KJ, Nkrumah FK, Pirie DJ. Measles epidemic in Harare, Zimbabwe, despite high measles immunization coverage rates. Bull World Health Organ 1991; 69 (2): 213-9. |
[32] | Morley D. Severe Measles. In: Paediatric Priorities in the Developing World, Butterworts 1979: 207-30. |
[33] | Garnett GP. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis 2005; 191 Suppl 1: S97-106. |
[34] | Willingham E, Helf L. What is Herd Immunity? Available on www.pbs.org/wgbh/nova/body/herd-immunity.html [Accessed 06 December 2015]. |
[35] | John TJ, Samuel R. Herd immunity and herd effect: new insights and definitions. Euro J Epidemiol 2000; 16 (7): 601-6. |
[36] | Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature 1985; 318(6044): 323-9. |
[37] | Fine P, Eames K, Heymann DL. "Herd immunity": a rough guide. Clin Infect Dis 2011; 52(7): 911-6. |
[38] | Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev 1993; 15(2): 265-302. |
[39] | Nokes DJ, Anderson RM. Measles, mumps, and rubella vaccine: what coverage to block transmission? Lancet 1988; 2(8624): 1374. |
APA Style
Tawanda Marufu, Seter Siziya, Willard Tinago. (2016). Impact of Vaccination on Measles Transmission Patterns in Gweru City, Zimbabwe, 1960-89. European Journal of Preventive Medicine, 4(3), 65-72. https://doi.org/10.11648/j.ejpm.20160403.13
ACS Style
Tawanda Marufu; Seter Siziya; Willard Tinago. Impact of Vaccination on Measles Transmission Patterns in Gweru City, Zimbabwe, 1960-89. Eur. J. Prev. Med. 2016, 4(3), 65-72. doi: 10.11648/j.ejpm.20160403.13
AMA Style
Tawanda Marufu, Seter Siziya, Willard Tinago. Impact of Vaccination on Measles Transmission Patterns in Gweru City, Zimbabwe, 1960-89. Eur J Prev Med. 2016;4(3):65-72. doi: 10.11648/j.ejpm.20160403.13
@article{10.11648/j.ejpm.20160403.13, author = {Tawanda Marufu and Seter Siziya and Willard Tinago}, title = {Impact of Vaccination on Measles Transmission Patterns in Gweru City, Zimbabwe, 1960-89}, journal = {European Journal of Preventive Medicine}, volume = {4}, number = {3}, pages = {65-72}, doi = {10.11648/j.ejpm.20160403.13}, url = {https://doi.org/10.11648/j.ejpm.20160403.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ejpm.20160403.13}, abstract = {A study was carried out in Gweru urban district (population-158233) in Zimbabwe to determine the impact of measles vaccine applied at 9 months of age on measles transmission patterns. A retrospective observational study that used data from measles vaccination records and measles disease surveillance was conducted. Linear regression analysis and the chi-squared test for linear trend (χ2) were used to investigate linear relationships at a 5% significance level. Vaccine coverage rates were 0% in pre-vaccination era in 1960-70 and 2-92% in 1971-89 (median=65, Q1=34, Q3=88) when they significantly linearly increased (p90% incidence rates significantly linearly declined (p80% (1984-89), proportion of vaccine failures among cases aged 60-119 months was significantly higher than at vaccine coverage rates of 80%. In age group 60-119 months incidence rates significantly linearly increased as vaccine coverage rates increased (Slope: +29.88, 95 CI [13.95, 45.82]). In pre-vaccination era, and at vaccine coverage rates of 80% some 75% of all reported measles cases occurred by age 36-47 months, 48-59 months and 72-83 months respectively. In conclusion, measles incidence rates declined at vaccine coverage rates of >90%, while measles vaccine failures significantly increased as vaccine coverage rates increased. Increasing measles vaccination coverage led to shift of age at infection from age group <59 months to age group 60-119 months and decline in rates of measles transmission.}, year = {2016} }
TY - JOUR T1 - Impact of Vaccination on Measles Transmission Patterns in Gweru City, Zimbabwe, 1960-89 AU - Tawanda Marufu AU - Seter Siziya AU - Willard Tinago Y1 - 2016/04/13 PY - 2016 N1 - https://doi.org/10.11648/j.ejpm.20160403.13 DO - 10.11648/j.ejpm.20160403.13 T2 - European Journal of Preventive Medicine JF - European Journal of Preventive Medicine JO - European Journal of Preventive Medicine SP - 65 EP - 72 PB - Science Publishing Group SN - 2330-8230 UR - https://doi.org/10.11648/j.ejpm.20160403.13 AB - A study was carried out in Gweru urban district (population-158233) in Zimbabwe to determine the impact of measles vaccine applied at 9 months of age on measles transmission patterns. A retrospective observational study that used data from measles vaccination records and measles disease surveillance was conducted. Linear regression analysis and the chi-squared test for linear trend (χ2) were used to investigate linear relationships at a 5% significance level. Vaccine coverage rates were 0% in pre-vaccination era in 1960-70 and 2-92% in 1971-89 (median=65, Q1=34, Q3=88) when they significantly linearly increased (p90% incidence rates significantly linearly declined (p80% (1984-89), proportion of vaccine failures among cases aged 60-119 months was significantly higher than at vaccine coverage rates of 80%. In age group 60-119 months incidence rates significantly linearly increased as vaccine coverage rates increased (Slope: +29.88, 95 CI [13.95, 45.82]). In pre-vaccination era, and at vaccine coverage rates of 80% some 75% of all reported measles cases occurred by age 36-47 months, 48-59 months and 72-83 months respectively. In conclusion, measles incidence rates declined at vaccine coverage rates of >90%, while measles vaccine failures significantly increased as vaccine coverage rates increased. Increasing measles vaccination coverage led to shift of age at infection from age group <59 months to age group 60-119 months and decline in rates of measles transmission. VL - 4 IS - 3 ER -